소개 소식 자료실 Drug Screening Service STR,QC&서비스 특허&기탁 NGS & Drug Test Info. 생명연구자원 기탁등록보존 배양세포 클러스터 오가노이드분양 세포주분양

최신정보

2020_Establishment and characterization of 18 human colorectal cancer cell lines

조회수 : 744회

이름 : 관리자

2022-03-25 13:34:11

링크주소 : https://www.nature.com/articles/s41598-020-63812-z

Establishment and characterization of 18 human colorectal cancer cell lines
Sci Rep. 2020 Apr 22;10(1):6801

Colorectal cancer (CRC) represents the third most frequently diagnosed malignancy worldwide and is the second most common cause of tumor-associated mortalities in Korea. Due to the disease's aggressive behavior, the 5-year survival rate for CRC patients remains unpromising. Well-characterized cell lines have been used as a biological model for studying the biology of cancer and developing novel therapeutics. To assist in vitro studies, 18 CRC cell lines (SNU-1566, SNU-1983, SNU-2172, SNU-2297, SNU-2303, SNU-2353B, SNU-2359, SNU-2373B, SNU-2407, SNU-2423, SNU-2431, SNU-2465, SNU-2493, SNU-2536C, SNU-2621B, SNU-NCC-61, SNU-NCC-376, and SNU-NCC-377) derived from Korean patients were established and characterized in the present study. General characteristics of each cell line including doubling time, in vitro morphology, mutational profiles, and protein expressions of CRC-related genes were described. Whole exome sequencing was performed on each cell line to configure mutational profiles. Single nucleotide variation, frame shift, in-frame deletions and insertions, start codon deletion, and splice stop codon mutation of various genes were found and classified based on their pathogenicity reports. In addition, cell viability was assayed to measure their sensitivities to 24 anti-cancer drugs including anti-metabolites, kinase inhibitors, histone deacetylase inhibitors, alkylating inhibitors, and topoisomerase inhibitors, all widely used for various cancers. On testing, five CRC cell lines showed MSI, of which MLH1 or MSH6 gene was mutated. These newly established CRC cell lines can be used to investigate biological characteristics of CRC, particularly for investigating gene alterations associated with CRC.
목록

총게시물 : 15개(현재페이지 : 1/총 페이지 : 1)

제목 작성일 조회수
15 2022_Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses 2022-03-25 930
14 2021_Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies 2022-03-25 998
13 2020_Establishment and characterization of 18 human colorectal cancer cell lines 2022-03-25 745
12 2019_Establishment and Characterization of 10 Human Pancreatic Cancer Cell Lines Including a HER2 Overexpressed Cell Line 2022-03-25 581
11 폐암세포주 'SNU-3173'_EGFR Exon 20 Insertion Mutation 세포주 2019-09-06 3624
10 대장암세포주 Early-Onset Colorectal Cancers_NCC-375, SNU-1460, SNU-1826, SNU-2446 2019-06-26 2991
9 대장암세포주(SNU-2335A, SNU-2404A, SNU-2414A)와 복막전이된 세포주(SNU-2335D, SNU-2404B, SNU-2414B) 2019-06-26 2947
8 직장암세포주의 방사선 내성세포주를 구축(SNU-61R80Gy, SNU-283R80Gy, SNU-503R80Gy) 2019-06-26 2364
7 new SNU breast cancer cell lines 세포주 분양개시 2014-09-15 7637
6 SNU-2535, EML4-ALK positive lung cancer cell line 보고 2013-06-07 9325
5 SNU lung cancer cell lines 논문 2011-07-12 9171
4 SNU colorectal cancer cell lines 논문 2011-07-12 8179
3 SNU 간암세포주들의 nude mouse에서의 종양형성능 2007-08-17 14235
2 KCLB세포주를 이용한 논문을 등록해 주세요. 2007-02-16 13193
1 홈페이지가 개편 되었습니다. 2006-12-22 11021
‹ 이전 1

Korean Cell Line Bank, Korean Cell Line Research Foundation,
101, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
대표자 : 박재갑 | 개인정보보안책임자 : 신영경 | 사업자 등록번호 : 208-82-03887
통신판매업 신고 제2015-서울혜화-0125호 | Tel : 82-2-3668-7915
Fax : 82-2-742-0021 | Email : kclb@kclb.kr

KCLB (C) is a registered mark of Korean Cell Line Bank. All rights reserved. 1998~2015